Source:Cell Metabolism, Volume 24, Issue 3
Author(s): Daniel J. Drucker
The lack of reproducibility of preclinical experimentation has implications for sustaining trust in and ensuring the viability and funding of the academic research enterprise. Here I identify problematic behaviors and practices and suggest solutions to enhance reproducibility in translational research.
Teaser
Reproducibility challenges in preclinical research threaten the integrity and viability of our research enterprise. Here Drucker discusses the complexity of methodological, technical, and ethical issues contributing to lack of reproducibility and suggests options for discussion that may enhance the reproducibility and translational relevance of preclinical studies.http://ift.tt/2cDNTas
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου